Home LiteratureArticle Details
PMID: 197594 Published · ppublish English Journal Article

Antibodies to human coronavirus OC43 measured by radial haemolysis in gel.

Scandinavian journal of infectious diseases ·Vol. 9 ·No. 2 ·1977-00-00 ·Pages 75-7

Riski H, Hovi T, Väänänen P, Penttinen K

Abstract

An application of the haemolysis-in-gel (HIG) technique was developed to quantitate antibodies against the human coronavirus OC43. Preinfection and convalescent sera from two patients with verified OC43 infection showed a significant increase in antibody titres measured by HIG as well as by haemagglutination-inhibition (HI). 241 of the other 306 sera tested (80%) caused radial haemolysis in gels containing viral antigen-sensitized erythrocytes and complement. No haemolysis was seen in gels prepared with unifected material. Correlation of the diameter of the haemolysis ring to the respective HI titre was highly significant. However, 62 sera (20%) with HI titres between 8 and 320 were negative in the HIG. Attempts to show that these sera contained nonspecific inhibitors of haemagglutination were unsuccessful. OC43 HI and HIG probably measure different antibody ppulations.

MeSH Terms
Antibodies, Viral/analysis Antibody Specificity Antigens, Viral Coronaviridae/immunology Coronaviridae Infections/immunology Hemagglutination Inhibition Tests Hemolytic Plaque Technique Humans
Chemicals
Antibodies, Viral Antigens, Viral
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Riski H
Hovi T
Väänänen P
Penttinen K
Article Info
Journal
Scandinavian journal of infectious diseases
Abbr.
Scand J Infect Dis
ISSN
0036-5548
Published
1977-00-00
Pages
75-7
Language
English
Region
England
NLM ID
0215333
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com